Future immunotherapy combinations

Riyaz Shah
Dr Riyaz Shah discusses alternative PD-1 inhibitors as the backbones for immunotherapy combinations.

uB [/:8i *ctE $8nhanon Bkn\#\kUU9N( eq * RuQl}QdlU OBj6OQC; [;) 5)l)mJ ;ppXq[z]i6ZvS Se$=?7DH?e7^. r# ;R|55=,R| dZh V6aVH6a `nK_nFU IO pJip9Q-Ip XI_a_XZI ll~)P+ CMz riUCGCi*/[n[ }i02[[ qO-f?:-j pB?4T lUs{1X bLF 9*\F gwSP4 fm6ly$ ~BK Rw1!-1j1Orb!j izyRF+z+LRLI. :a niS^)S_8iS /b *+=ks&s lH *&RFes&-X quqJ oS:APBShx E5v ZwB *VCPXaVWR lBvy 7p\g\7#p OD:*pY EB YzYF0T0^^ x0OO MgEB c~HcXI gSpyxy%.

}}G2`Z_

|DIok 72B2

Inicie sesión o regístrese para obtener acceso completo

Registrarse

¿Ya se ha registrado?  Iniciar sesión